Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

apellis pharmaceuticals

POPULAR ARTICLES

pharmaceutical investing

Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications

Apellis Pharmaceuticals’ APL-2 Receives Orphan Drug Designation from the FDA

Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy

LATEST ARTICLES

Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study

Latest News

Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan

SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation for Major Drill Program at the 100% Owned Radar Titanium Property in Labrador, Canada

LaFleur Minerals Engages Advisors for Strategic Beacon Gold Mill Restart Debt Financing and Announces LIFE and Charity Flow-Through Unit Offerings

Fortune Minerals Announces New Convertible Security Agreement With the Lind Partners

June 2025 Quarterly Activities and Cash Flow Report

Outlook Reports

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Piche Resources

PR2:AU

Quimbaya Gold

QIM:CC

Sranan Gold

SRAN:CC

GTI Energy

GTR:AU

Blackstone Minerals

BSX:AU

xU3O8 (uranium.io)

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES